Ignite Creation Date:
2024-05-06 @ 2:03 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04209621
Status:
TERMINATED
Last Update Posted:
2022-03-09
First Post:
2019-12-21
Brief Title:
Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
200016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Heart Lung and Blood Institute NHLBI
Lead Sponsor Class:
NIH
Responsible Party:
Clare Sun MD
Responsible Party Title:
Staff Clinician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Institutes of Health Clinical Center CC
Old Name:
None
Old Organization:
None